Literature DB >> 9416408

TGF beta-1 regulation of VEGF production by breast cancer cells.

D Donovan1, J H Harmey, D Toomey, D H Osborne, H P Redmond, D J Bouchier-Hayes.   

Abstract

BACKGROUND: Angiogenesis is essential for tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is the most potent angiogenic factor identified to date. TGF beta-1 acts as an indirect angiogenic agent.
METHODS: VEGF and TGF beta-1 were measured in the serum of breast cancer patients and age-matched controls and in tumor tissue of cancer patients by ELISA. VEGF protein and mRNA expression by breast tumor cell lines were examined, and the effect of TGF beta-1 on VEGF production in these cells was assessed.
RESULTS: VEGF levels were significantly higher (P = .03) in the serum of patients with breast cancer compared to age-matched controls. A positive correlation was found between serum (r = 0.539) and tumor tissue (r = 0.688) levels of VEGF and TGF beta-1. Metastatic MDA-MB-231 breast cancer cells produce more VEGF than do the primary BT474 cells. TGF beta-1 significantly (P < .05) increased production of VEGF.
CONCLUSIONS: Breast cancer cells constitutively produce VEGF protein and mRNA. There is a relationship between VEGF and TGF beta-1 levels in breast cancer patients, and TGF beta-1 regulates VEGF expression by breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416408     DOI: 10.1007/bf02303745

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

Review 1.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 2.  Inhibition of vascular endothelial growth factor in the treatment of solid tumors.

Authors:  Kim Margolin
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

3.  Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models.

Authors:  Chandraiah Godugu; Apurva R Patel; Ravi Doddapaneni; Srujan Marepally; Tanise Jackson; Mandip Singh
Journal:  J Control Release       Date:  2013-07-07       Impact factor: 9.776

4.  Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.

Authors:  Catalina Suarez-Cuervo; Melinda A Merrell; Latania Watson; Kevin W Harris; Eben L Rosenthal; H Kalervo Väänänen; Katri S Selander
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro.

Authors:  Wataru Matsuyama; Ryuji Kubota; Teruto Hashiguchi; Hiroaki Momi; Masaharu Kawabata; Masanori Nakagawa; Kimiyoshi Arimura; Mitsuhiro Osame
Journal:  Immunology       Date:  2002-05       Impact factor: 7.397

6.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

7.  Vascular endothelial growth factor and breast cancer risk.

Authors:  Katherine W Reeves; Roberta B Ness; Roslyn A Stone; Joel L Weissfeld; Victor G Vogel; Robert W Powers; Francesmary Modugno; Jane A Cauley
Journal:  Cancer Causes Control       Date:  2008-11-06       Impact factor: 2.506

8.  Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.

Authors:  Tobias Bäuerle; Heidegard Hilbig; Sönke Bartling; Fabian Kiessling; Astrid Kersten; Annette Schmitt-Gräff; Hans-Ulrich Kauczor; Stefan Delorme; Martin R Berger
Journal:  Neoplasia       Date:  2008-05       Impact factor: 5.715

9.  [Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].

Authors:  H M Kvasnicka; J Thiele; P Staib; K Engels; S Kriener; A Schmitt-Graeff
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

10.  Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.

Authors:  Jason Kindrachuk; Victoria Wahl-Jensen; David Safronetz; Brett Trost; Thomas Hoenen; Ryan Arsenault; Friederike Feldmann; Dawn Traynor; Elena Postnikova; Anthony Kusalik; Scott Napper; Joseph E Blaney; Heinz Feldmann; Peter B Jahrling
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.